1Charpentier G,Vaur L,Halimi S,et al.Predictor of response to glimepiride in patients with type 2 diabetes mellitus[].Diabetes and Metabolism.2001
2Schade DS,Jovanovic L,Schneide J.A placebo-controlled,randomized study of glimepiride in patients with type 2 diabetes mellitus for whom diet therapy is unsuccessful[].Journal of Clinical Pharmacology.1998
3Raptis SA,Hatziagelaki E,Dimitriadis G,et al.Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations of the fasting and postprandial state in normal men[].Experimental and Clinical Endocrinology and Diabetes.1999
6People's Daily Online. China has annual increase of 1. 2 million diabetes patients [ EB/OL]. [2008- 02- 29]. http://english, peopledaily, com. cn /200011/14/eng 20001114_55162. html.
7World health organization. Definition, diagnosis and classification of diabetes mellitus and its complication[ J]. WHO/NCD/NCS, 1999:31.
8Dan-yan Xu. Effects of Glimepiride on Metabolic parameters and cardiovas- cular risk factors in patients with newly diagnosed type 2 diabetes mellitus [ J ]. Diabetes Research and Clinical Practice, 2010,88:71-75.
9Gonzalez-Ortiz, M. Efficacy of glimepiride/meffonnin combination versus glib- enelamide/mefformin in patients with uncontrolled type 2 diabetes mellitus [ J ]. Diabetes Complications, 2009, 23(6) :376-379.
10Dills, D. G. and J. Schneider. Clinical evaluation of glimepiride versus gly- buride in NIDDM in a double-blind comfxarative study. Glimepiride/Glyburide Research Group[J]. Horm Metab Res,1996,28(9):426-429.
